Untitled-1.png
  • black-back-closed-envelope-shape
  • White Instagram Icon
  • White Facebook Icon
  • White LinkedIn Icon

Copyright ©2019 by Sanomics Limited. All rights reserved.

OncoSnapTM is a pioneering tumor tissue profiling test which screens for clinically relevant somatic mutations of 130 genes in solid tumor tissues by using NGS technologies, and offers FDA-approved therapies undergoing clinical trials.

Able to detect single nucleotide variations (SNVs), insertions and deletions (indels), selected fusions and copy number alterations

Sample types: FFPE Block or 5μm unstained FFPE slides mounted on slides

Turnaround time: 14 working days upon sample arrival

Why use OncoSnapTM?

99.1% analytical sensitivity

>99.9% specificity

Encompassing Coverage

-Detect SNVs, Indels down to 5% VAF, CNAs at ± 2 copies in 130 genes and fusion of selected genes.

Examples of Solid Tumor Can Be Targeted

Untitled-3.png

       ​Skin                  

Hepatobiliary  

Brain

Endocrine

Head & Neck

Untitled-4.png

         Lung

 Gastrointestinal

Gynecologic

Breast

Genitourinary

Gene List